Condition: Cirrhosis · Registered on Transplant List · Sponsor: Centre Hospitalier Universitaire de Besancon
The aim of this multicenter prospective interventional pilot study is to describe the evolution of myocardial fibrosis in cirrhotic patients before and after liver transplantation (LT). Through multimodal analysis of myocardial function and architecture, and analysis of specific markers of inflammation, we aim to explore the following hypotheses: 1) systemic inflammation promotes myocardial fibrosis in cirrhotic patients and could be an early marker of cirrhotic cardiomyopathy; 2) LT allows resolution of myocardial fibrosis by preventing the bacterial translocation that favors the development of deleterious systemic inflammation.
This description comes directly from the study's public registry record.
Delphine WEIL, MD, PHD · +33381669457 · dweil@chu-besancon.fr
Always discuss trial participation with your own doctor first.
| CHU Besancon - Hopital Minjoz | Besançon, France | Recruiting |
| CHU Dijon - Hopital François Mitterrand | Dijon, France | Recruiting |
| CHRU Nancy - Hôpital de Brabois | Nancy, France | Recruiting |
| CHU Strasbourg - Hopital de HautePierre | Strasbourg, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06327308